Osmolex ER is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Vertical Pharmaceuticals, Llc. The primary component is Amantadine.
| Product ID | 68025-021_ce2e1a99-33cb-84e4-e053-2a95a90a71e6 |
| NDC | 68025-021 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Osmolex ER |
| Generic Name | Amantadine |
| Dosage Form | Tablet, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-05-05 |
| Marketing End Date | 2023-06-30 |
| Marketing Category | NDA / |
| Application Number | NDA209410 |
| Labeler Name | Vertical Pharmaceuticals, LLC |
| Substance Name | AMANTADINE |
| Active Ingredient Strength | 161 mg/1 |
| Pharm Classes | Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Marketing Start Date | 2022-05-05 |
| Marketing End Date | 2023-06-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 68025-021 | Osmolex ER | amantadine |
| 68025-074 | Osmolex ER | amantadine |
| 68025-075 | Osmolex ER | amantadine |
| 68025-076 | Osmolex ER | amantadine |
| 68025-077 | Osmolex ER | amantadine |
| 70482-075 | OSMOLEX ER | amantadine |
| 70482-076 | OSMOLEX ER | amantadine |
| 46708-246 | amantadine | amantadine |
| 46708-586 | Amantadine | Amantadine |
| 60687-422 | Amantadine | Amantadine |
| 62332-246 | amantadine | amantadine |
| 62332-586 | Amantadine | Amantadine |
| 70482-085 | GOCOVRI | AMANTADINE |
| 70482-170 | GOCOVRI | AMANTADINE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() OSMOLEX ER 87639712 5770506 Live/Registered |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelôsségû Társaság 2017-10-10 |